Since genetic abnormalities in AML can be considered as prognostic risk factors, there may be correlations between them and the overexpression of TIM-3 in leukemia cells and/or immune cells in AML; hence more studies are required in this aspect. The gene discussed is HAVCR2; the disease is acute myeloid leukemia.